541 related articles for article (PubMed ID: 22688660)
21. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
22. ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment.
Stepp H; Beck T; Pongratz T; Meinel T; Kreth FW; Tonn JCh; Stummer W
J Environ Pathol Toxicol Oncol; 2007; 26(2):157-64. PubMed ID: 17725542
[TBL] [Abstract][Full Text] [Related]
23. Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment.
Schimanski A; Ebbert L; Sabel MC; Finocchiaro G; Lamszus K; Ewelt C; Etminan N; Fischer JC; Sorg RV
J Photochem Photobiol B; 2016 Oct; 163():203-10. PubMed ID: 27588717
[TBL] [Abstract][Full Text] [Related]
24. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
25. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
[TBL] [Abstract][Full Text] [Related]
26. 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors.
Johansson A; Palte G; Schnell O; Tonn JC; Herms J; Stepp H
Photochem Photobiol; 2010; 86(6):1373-8. PubMed ID: 20854414
[TBL] [Abstract][Full Text] [Related]
27. Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapy.
Nakayama T; Otsuka S; Kobayashi T; Okajima H; Matsumoto K; Hagiya Y; Inoue K; Shuin T; Nakajima M; Tanaka T; Ogura SI
Sci Rep; 2016 Nov; 6():36478. PubMed ID: 27857072
[TBL] [Abstract][Full Text] [Related]
28. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
29. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.
Harada Y; Murayama Y; Takamatsu T; Otsuji E; Tanaka H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742921
[TBL] [Abstract][Full Text] [Related]
30. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
31. Relationship of protoporphyrin IX synthesis to photodynamic effects by 5-aminolaevulinic acid and its esters on various cell lines derived from the skin.
Lee JB; Choi JY; Chun JS; Yun SJ; Lee SC; Oh J; Park HR
Br J Dermatol; 2008 Jul; 159(1):61-7. PubMed ID: 18489589
[TBL] [Abstract][Full Text] [Related]
32. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
[TBL] [Abstract][Full Text] [Related]
33. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
34. Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition.
Barron GA; Moseley H; Woods JA
J Photochem Photobiol B; 2013 Sep; 126():87-96. PubMed ID: 23911860
[TBL] [Abstract][Full Text] [Related]
35. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
[TBL] [Abstract][Full Text] [Related]
36. ALA-PpIX mediated photodynamic therapy of malignant gliomas augmented by hypothermia.
Fisher CJ; Niu C; Foltz W; Chen Y; Sidorova-Darmos E; Eubanks JH; Lilge L
PLoS One; 2017; 12(7):e0181654. PubMed ID: 28759636
[TBL] [Abstract][Full Text] [Related]
37. Ablation efficacy of 5-aminolevulinic acid-mediated photodynamic therapy on human glioma stem cells.
Omura N; Nonoguchi N; Fujishiro T; Park Y; Ikeda N; Kajimoto Y; Hosomi R; Yagi R; Hiramatsu R; Furuse M; Kawabata S; Fukunaga K; Kuroiwa T; Nakano I; Wanibuchi M
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103119. PubMed ID: 36336324
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
39. Experimental study to understand nonspecific protoporphyrin IX fluorescence in brain tissues near tumors after 5-aminolevulinic acid administration.
Masubuchi T; Kajimoto Y; Kawabata S; Nonoguchi N; Fujishiro T; Miyatake S; Kuroiwa T
Photomed Laser Surg; 2013 Sep; 31(9):428-33. PubMed ID: 23869519
[TBL] [Abstract][Full Text] [Related]
40. 5-Aminolevulinic acid enhances mitochondrial stress upon ionizing irradiation exposure and increases delayed production of reactive oxygen species and cell death in glioma cells.
Ueta K; Yamamoto J; Tanaka T; Nakano Y; Kitagawa T; Nishizawa S
Int J Mol Med; 2017 Feb; 39(2):387-398. PubMed ID: 28035368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
